Skip to main content

Table 1 Demographic and clinical data of patients on anti-VEGF therapy and the control group. Data are shown as mean (SEM)

From: Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections

 

AMD 20x

AMD one year

Control

N

17

25

18

Male/Female

12/5

10/15

8/10

Age (year)

71.12 (4.27)

74.84 (8.83)

73.33 (6.92)

BCVA (ETDRS)

63.60 (9.39)

66.00 (11.25)

82.28 (3.91)*

CNV type (1/2)

8/9

11/14

N/A

No. of IVI

20.29 (0.77)

6.84 (1.18)

N/A

Follow-up (months)

39.35 (8.24)

12.04 (0.73)

N/A

  1. Group AMD 20x: Long-term treatment of at least 20 IVI
  2. Group one year. One year of T&E protocol treatment
  3. IVI- intravitreal injections
  4. *p < 0.05 (Kruskal–Wallis and Fisher-exact test)
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us